These 10 antibodies recognize different epitopes of the SARS-CoV-2 Spike glycoprotein, nine of which are SARS-CoV-2-specific and do not cross-react with other human coronaviruses
A crucial part of the global effort to stem the spread of the pandemic is the development of tests that can rapidly identify infections in asymptomatic people